These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 22622628
1. Anxiety and methylphenidate in attention deficit hyperactivity disorder: a double-blind placebo-drug trial. Moshe K, Karni A, Tirosh E. Atten Defic Hyperact Disord; 2012 Sep; 4(3):153-8. PubMed ID: 22622628 [Abstract] [Full Text] [Related]
2. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder. Gorman EB, Klorman R, Thatcher JE, Borgstedt AD. J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317 [Abstract] [Full Text] [Related]
3. The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention-deficit hyperactivity disorder. Hawk LW, Yartz AR, Pelham WE, Lock TM. Psychopharmacology (Berl); 2003 Jan; 165(2):118-27. PubMed ID: 12417963 [Abstract] [Full Text] [Related]
4. Clinical evaluation of subjective and objective changes in motor activity and attention in children with attention-deficit/hyperactivity disorder in a double-blind methylphenidate trial. Konrad K, Günther T, Heinzel-Gutenbrunner M, Herpertz-Dahlmann B. J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):180-90. PubMed ID: 15910203 [Abstract] [Full Text] [Related]
5. Sex differences in attentional performance and their modulation by methylphenidate in children with attention-deficit/hyperactivity disorder. Günther T, Herpertz-Dahlmann B, Konrad K. J Child Adolesc Psychopharmacol; 2010 Jun; 20(3):179-86. PubMed ID: 20578930 [Abstract] [Full Text] [Related]
6. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T. J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077 [Abstract] [Full Text] [Related]
11. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder. Bental B, Tirosh E. J Clin Psychopharmacol; 2008 Feb; 28(1):89-92. PubMed ID: 18204348 [Abstract] [Full Text] [Related]
12. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents. Biederman J, Pliszka SR. J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848 [Abstract] [Full Text] [Related]
13. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial. Salehi B, Imani R, Mohammadi MR, Fallah J, Mohammadi M, Ghanizadeh A, Tasviechi AA, Vossoughi A, Rezazadeh SA, Akhondzadeh S. Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb 01; 34(1):76-80. PubMed ID: 19815048 [Abstract] [Full Text] [Related]
16. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. Barrickman LL, Perry PJ, Allen AJ, Kuperman S, Arndt SV, Herrmann KJ, Schumacher E. J Am Acad Child Adolesc Psychiatry; 1995 May 01; 34(5):649-57. PubMed ID: 7775360 [Abstract] [Full Text] [Related]
17. Influence of methylphenidate on motor performance and attention in children with developmental coordination disorder and attention deficit hyperactive disorder. Bart O, Daniel L, Dan O, Bar-Haim Y. Res Dev Disabil; 2013 Jun 01; 34(6):1922-7. PubMed ID: 23584172 [Abstract] [Full Text] [Related]
19. Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study. Jafarinia M, Mohammadi MR, Modabbernia A, Ashrafi M, Khajavi D, Tabrizi M, Yadegari N, Akhondzadeh S. Hum Psychopharmacol; 2012 Jul 01; 27(4):411-8. PubMed ID: 22806822 [Abstract] [Full Text] [Related]